ANTENGENE-B 06996Hong Kong Stock Exchange

3.1903.63%( -0.120 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
ANTENGENE-B (06996) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-11-20
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG039571008

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)123.53M89/112
Net Profit (Last FY)-280.42M91/125
ROE (Last FY)-37.22%93/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Jay Mei Executive Director
Bing Hou Executive Director
Jing Qian Independent Non-Executive Director
Sheng Tang Independent Non-Executive Director
Rafael Fonseca Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-03.

About this page

This page shows ANTENGENE-B (06996) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.